Female Infertility Diagnosis and Treatment Market Booming Worldwide with Latest Trend and Future Scope by 2029

Female Infertility Diagnosis and Treatment Market is anticipated to grow at a significant CAGR of 5.6% during the forecast period. Increasing infertility and changing lifestyles drive the growth of the global female infertility diagnosis and treatment market. For instance, according to the center for disease control and prevention in December 2021, in the US, around 13.8% of women aged 15-49 have impaired fecundity, and 26% of married women of the same age group are suffered from impaired fecundity. This, in turn, is expected to propel the demand for female infertility diagnosis and treatment. Furthermore, the rising trends of surrogacy, the growing infertility rate among females, and new technologies to avoid multiple embryo implants are estimated to be the major factors that are contributing to the growth of the market.

However, certain factors restrained the growth of the market, such as the high cost of infertility treatment, and the low accuracy rate of the treatment. Moreover, the social stigma related to infertility treatment is another factor that may hinder the global female infertility diagnosis and treatment market across the globe.

To Request a Sample of our Report on Female Infertility Diagnosis and Treatment Market:  https://www.omrglobal.com/request-sample/female-infertility-market-size

Female Infertility Diagnosis and Treatment Market Segmentation

 By Diagnosis

  • Ovulation Testing
  • Hysterosalpingography (HSG)
  • Hysteroscopy
  • Imaging Testing
  • Ovarian Reserve Testing
  • Hormonal Level Testing
  • Genetic Testing
  • Others (Laparoscopy)

By Treatment  

  • Drugs
  • Surgery
  • Intrauterine Insemination (IUI)
  • Assisted Reproductive Technology (ART)

By End-User

  • Hospitals and Clinics
  • Homecare
  • Pathology and Diagnostic Centers

A full Report of Female Infertility Diagnosis and Treatment Market is Available @  https://www.omrglobal.com/industry-reports/female-infertility-market-size

Regional Analysis                                                                                                                                                                            

North America                                                                                                           

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East and Africa

Company Profiles 

  • Cook Group Inc.
  • Eli Lilly & Co.
  • Esco Group
  • Fairhaven Health
  • Ferring B.V.
  • Fujifilm Irvine Scientific, Inc.
  • GlaxoSmithKline Plc.
  • Merck KGaA
  • Princeton BioMeditech Corp.
  • Tempest Therapeutics, Inc.

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/female-infertility-market-size

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404